Radiotherapy in elderly patients with inoperable esophageal cancer: Is there a benefit?

Strahlentherapie und Onkologie

Volumn 188, Issue 3, 2012, Pages 226-234

  Semrau, R ^a   Herzog, S L ^a   Vallbohmer D ^a   Kocher, M ^a   Holscher A ^a   Muller R P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Carcinoma; Chemoradiotherapy; Elderly; Esophageal neoplasms; Treatment outcome

Indexed keywords

CISPLATIN; CORTICOSTEROID; FLUOROURACIL; METOCLOPRAMIDE; SEROTONIN 3 ANTAGONIST;

ADENOCARCINOMA; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA;

EID: 84862637764     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0039-2     Document Type: Article

References (24)

1. Alexiou C, Beggs D, Salama FD et al (1998) Surgery for esophageal cancer in elderly patients: the view from Nottingham. J Thorac Cardiovasc Surg 116(4):545-553 (Pubitemid 28460619)
2. Vallböhmer D, Hölscher AH, Brabender J et al (2008) Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a difference? Dis Esophagus 21:596-600
3. Sabel MS, Smith JL, Nava HR et al (2002) Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 9(2):210-214 (Pubitemid 34259710)
4. Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598
5. al-Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277-284 (Pubitemid 27020584)
6. Patonay P, Naszaly A, Mayer A (2007) Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer. Strahlenther Onkol 183:94-98
7. Brunner TB, Rupp A, Melzner W et al (2008) Esophageal cancer. A prospective phase II study of concomitant- boost external-beam chemoradiation with a top-up endoluminal boost. Strahlenther Onkol 184:15-22
8. Schroder W, Bollschweiler E, Kossow C, Hölscher AH (2006) Preoperative risk analysis-a reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg 391:455-460 (Pubitemid 44337605)
9. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481
10. Cox DR, Oakes D (1984) Analysis of survival data. Chapman Hall, London
11. Leibl BJ, Vitz S, Schafer W et al (2011) Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery: early results and toxicity. Strahlenther Onkol 187:231-237
12. Ofner D, Devries AF, Schaberl-Moser R et al (2011) Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cTNxM0, low rectal cancer: a phase II study. Strahlenther Onkol 187:100-107
13. Nagy V, Coza O, Ordeanu C et al (2009) Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial. Strahlenther Onkol 185:177-183
14. Coia LR, Minsky BD, Berkey BA et al (2000) Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 patterns of care study. J Clin Oncol 18:455-462 (Pubitemid 30078526)
15. Tougeron D, Di Fiore F, Thureau S et al (2008) Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer 99:1586-1592
16. Anderson SE, Minsky BD, Bains M et al (2007) Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer 96:1823-1827 (Pubitemid 46912031)
17. Wolf M, Zehentmayr F, Niyazi M et al (2010) Longterm outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. Strahlenther Onkol 186:374-381
18. Hishikawa Y, Kurisu K, Taniguchi M et al (1991) Radiotherapy for carcinoma of the esophagus in patients aged eighty or older. Int J Radiat Oncol Biol Phys 20:685-688
19. Yamakawa M, Shiojima K, Takahashi M et al (1994) Radiation therapy for esophageal cancer in patients over 80 years old. Int J Radiat Oncol Biol Phys 30:1225-1232 (Pubitemid 24362537)
20. Takeuchi S, Ohtsu A, Doi T et al (2007) A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer. Am J Clin Oncol 30:607-611 (Pubitemid 350307186)
21. Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standarddose radiation therapy. J Clin Oncol 20:1167-1174 (Pubitemid 34177421)
22. Eloubeidi MA, Desmond R, Arguedas MR et al (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95:1434-1443
23. Tougeron D, Hamidou H, Scotte M et al (2010) Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer 10:510
24. Marquardt F, Rodel F, Capalbo G et al (2009) Molecular targeted treatment and radiation therapy for rectal cancer. Strahlenther Onkol 185:371-378